OBEMIRISK – Knowledge platform for assessing the risk of bisphenols on gut microbiota and its role in obesogenic phenotype: looking for biomarkers

The OBEMIRISK project responds to a «EFSA Partnering Grant» call. Its main objective is to develop a European platform for assessing the risks linked to Bisphenol A (BPA) and its analogues (BPS, BPF, etc.) in children, with an emphasis on the effects on the intestinal microbiota (dysbiosis) and the search for biomarkers in the predisposition to obesity.

• Researcher: Margarita Aguilera Gómez / Ana Rivas Velasco
• Group: TEC16-TERAPIAS AVANZADAS: DIFER-REGENACION-CANCER / E15-NUTRICION, DIETA, EVALUACION DE RIESGOS
• Center: University of Granada
• Rol in the project: Project coordinator
• Duration: 2018 – 2021

Página web del proyecto: https://www.efsa.europa.eu/en